Fundamentals, not a stock split, will determine whether the bull case for Eli Lilly continues.

Investors generally don't turn to pharmaceutical stocks with expectations of high growth in a short period of time. Instead, they scoop up these players for their promise of steady gains over the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

So, first of all, why would Eli Lilly want to launch a stock split? Companies generally execute such an operation after the stock price has soared to levels that may make it difficult for some ...

Wall Street’s appetite for weight-loss drug stocks over the past four years has powered Eli Lilly & Co. to consistently trade above $1,000 per share. Now, some see the pharma giant’s stock as primed ...

Within the span of 19 hours, weight loss drugmakers Novo Nordisk A/S and Eli Lilly & Co. offered wildly divergent views on where business is headed. After Novo shocked the market by warning sales ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

For aficionados of stock splits, it's an intriguing question: Will Eli Lilly (LLY +1.04%) be the next company to split its stock? It certainly might -- its stock price was recently $1,280 per share.